Not so fast. He use to utter that when asked about

Not so fast. He use to utter that when asked about it on twitter etc but a few months ago he changed his tune to if necessary, the company can execute that RS without shareholder consent and went into a lengthy blog about it. It was just another example of how Gerald has, at times, played fast and loose with what he says vs what is done. Now, we have to wait and see how this uplist happens. Many thought, again based on what Gerald had said, that he had hoped to uplist by mid 2014 or so. Obviously that didn't happen and it doesn't look like it will this year. I would guess that Gerald though certain things would help lift the stock price. He and his BOD have grossly miscalculated as nothing the company has done so far, not the launch of Lympro or so far the Orphan Status has done a thing to lift this stock out from the abyss that it has been since the July 30th faux pas when the company sat on bad news for weeks only to release it the day prior to announcement.

Gerald loves to talk about how the stock has appreciated over the last three years but fails to understand that many people will see a 2014 that, so far, has been dismal when looking at one's return on investment.

Putting this year aside, I am hoping 2015 finally comes together for this company. Many of us have been more than patient with a ceo that has seen his waist line get bigger while the stock price gets hammered and is off more the 50% from its yearly high.

My Agenda: To see Amarantus prosper so I can make a nice return on my investment.